Dimensional Fund Advisors
PGNX

Dimensional Fund Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Dimensional Fund Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-837,153
Closed -$3.18M – 3386
2020
Q1 		$3.18M Hold
837,153
– – ﹤0.01% 2562
2019
Q4 		$4.26M Sell
837,153
-3,600
-0.4% -$19K ﹤0.01% 2660
2019
Q3 		$4.25M Buy
840,753
+5,100
+0.6% +$25.4K ﹤0.01% 2650
2019
Q2 		$5.16M Buy
835,653
+121,862
+17% +$588K ﹤0.01% 2623
2019
Q1 		$3.31M Buy
713,791
+628,424
+736% +$2.84M ﹤0.01% 2773
2018
Q4 		$359K Buy
85,367
+40,297
+89% +$205K ﹤0.01% 3200
2018
Q3 		$283K Hold
45,070
– – ﹤0.01% 3264
2018
Q2 		$362K Hold
45,070
– – ﹤0.01% 3173
2018
Q1 		$336K Hold
45,070
– – ﹤0.01% 3161
2017
Q4 		$268K Sell
45,070
-125,369
-74% -$762K ﹤0.01% 3177
2017
Q3 		$1.25M Buy
170,439
+39,736
+30% +$252K ﹤0.01% 2952
2017
Q2 		$888K Buy
130,703
+46,389
+55% +$342K ﹤0.01% 2999
2017
Q1 		$796K Sell
84,314
-4,887
-5% -$48.8K ﹤0.01% 3019
2016
Q4 		$771K Sell
89,201
-169,130
-65% -$1.25M ﹤0.01% 3020
2016
Q3 		$1.64M Sell
258,331
-344,397
-57% -$2.08M ﹤0.01% 2829
2016
Q2 		$2.54M Sell
602,728
-4,600
-0.8% -$22.2K ﹤0.01% 2707
2016
Q1 		$2.65M Sell
607,328
-38,935
-6% -$173K ﹤0.01% 2694
2015
Q4 		$3.96M Sell
646,263
-12,117
-2% -$79.4K ﹤0.01% 2606
2015
Q3 		$3.77M Hold
658,380
– – ﹤0.01% 2619
2015
Q2 		$4.91M Sell
658,380
-12,071
-2% -$73K ﹤0.01% 2586
2015
Q1 		$4.01M Hold
670,451
– – ﹤0.01% 2636
2014
Q4 		$5.07M Hold
670,451
– – ﹤0.01% 2560
2014
Q3 		$3.48M Sell
670,451
-11,395
-2% -$56.8K ﹤0.01% 2666
2014
Q2 		$2.94M Sell
681,846
-26,218
-4% -$100K ﹤0.01% 2743
2014
Q1 		$2.9M Sell
708,064
-2,300
-0.3% -$11.8K ﹤0.01% 2744
2013
Q4 		$3.79M Buy
710,364
+1,161
+0.2% +$5.11K ﹤0.01% 2661
2013
Q3 		$3.57M Buy
709,203
+70,798
+11% +$384K ﹤0.01% 2680
2013
Q2 		$2.85M Buy
+638,405
New +$2.86M ﹤0.01% 2708

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Dimensional Fund Advisors's PGNX Position: Q2 2020 in Review

Dimensional Fund Advisors sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 837,153 shares — an estimated $3.18M sold.

Dimensional Fund Advisors first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $5.16M in Q2 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Dimensional Fund Advisors reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 837,153 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $3.18M.
  • Dimensional Fund Advisors first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
  • Dimensional Fund Advisors's Progenics Pharmaceuticals Inc position peaked at $5.16M in Q2 2019.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.